Drug-induced liver injury (DILI) is a frequent cause of acute liver failure and drug withdrawals. Liver organoids, as a ...

Ace Therapeutics recently unveiled a comprehensive suite of well-validated disease models tailored for gastroenterology lab research. NEW YORK, NY, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- ...

“We will determine the best dose for phase 2 trials based on data we obtained from earlier patient studies and new findings from our organoid models,” said a SillaJen official. BAL0891 is a new type ...

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...

Model more closely replicates natural environment of the pancreas, which will be essential for studying diabetes and ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

A study led by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the Broad Institute of MIT ...

SSRIs boosted the ability of T cells to kill cancer cells and suppressed tumor growth in both mouse and human tumor models.

Scientists created a new nanoparticle aimed at making ultrasound-based cancer therapy more safe and effective.

Manufacturing CAR T cells in the laboratory is expensive and time-consuming. An in vivo approach could get the powerful ...